Arsenal Medical, Inc.
Arsenal Medical is dedicated to transforming medicine with innovative biomaterials and devices. Founded by leading experts in materials science and chemistry, the company develops products to address unmet medical needs across various therapeutic areas. Their platform includes advanced biomaterials like NeoCast™ and ResQFoam™, which are designed for neurovascular occlusion and trauma treatment, respectively. Arsenal Medical's mission is to create thoughtfully designed medical solutions that improve patient outcomes and advance healthcare technology.
Industries
Nr. of Employees
small (1-50)
Arsenal Medical, Inc.
100 Beaver Street, Suite 302, Waltham, MA 02453
Patents
Products
Injectable shear‑responsive embolic material for neurovascular occlusion
An investigational injectable, shear‑responsive, in situ‑curing embolic biomaterial designed to be delivered through neurovascular catheters to penetrate distal vessels and achieve durable occlusion for neurovascular hemorrhagic and hypervascular tumor indications.
Rapidly expanding hydrophobic abdominal hemorrhage foam
A two‑component, rapidly expanding hydrophobic foam system developed to expand through the abdominal cavity and control non‑compressible hemorrhage as a bridge to surgery.
Injectable shear‑responsive embolic material for neurovascular occlusion
An investigational injectable, shear‑responsive, in situ‑curing embolic biomaterial designed to be delivered through neurovascular catheters to penetrate distal vessels and achieve durable occlusion for neurovascular hemorrhagic and hypervascular tumor indications.
Rapidly expanding hydrophobic abdominal hemorrhage foam
A two‑component, rapidly expanding hydrophobic foam system developed to expand through the abdominal cavity and control non‑compressible hemorrhage as a bridge to surgery.
Services
In-house development from materials formulation through device integration, preclinical testing, and preparation for clinical investigation.
Protocol design, trial execution, regulatory submissions, and regulatory pathway management to support investigational studies and device approvals.
In-house development from materials formulation through device integration, preclinical testing, and preparation for clinical investigation.
Protocol design, trial execution, regulatory submissions, and regulatory pathway management to support investigational studies and device approvals.
Expertise Areas
- Biomaterials development
- Interventional neurovascular embolization
- Trauma hemorrhage control
- Clinical trial management (early feasibility/first‑in‑human)
Key Technologies
- Shear‑responsive (shear‑thinning) injectable biomaterials
- In situ curing embolic formulations
- Rapidly expanding hydrophobic foam systems
- Solvent‑free polymer formulations
News & Updates
Treatment with NeoCast™ is pain-free and leads to rapid resorption of chronic subdural hematoma.
Internationally recognized clinician with over 35 years of interventional pain management expertise joins the board.
New publication in Advanced Healthcare Materials about NeoCast's design for durable embolization.
Data shows NeoCast™ met primary endpoints and enabled significant distal penetration of hypervascular brain tumors.
Interview with Upma Sharma, President and CEO of Arsenal Medical, about their innovative biomaterials.
Initial clinical results showing NeoCast™'s effectiveness in neurovascular embolization.
Treatment with NeoCast™ is pain-free and leads to rapid resorption of chronic subdural hematoma.
Internationally recognized clinician with over 35 years of interventional pain management expertise joins the board.
New publication in Advanced Healthcare Materials about NeoCast's design for durable embolization.
Data shows NeoCast™ met primary endpoints and enabled significant distal penetration of hypervascular brain tumors.
Interview with Upma Sharma, President and CEO of Arsenal Medical, about their innovative biomaterials.
Initial clinical results showing NeoCast™'s effectiveness in neurovascular embolization.